Home monitoring for children with low immunity after chemo
Part of Blood & lymphatic clinical trials.
This trial tests whether a small home monitoring device can help keep children safer after chemotherapy, especially when they're at risk of a low white blood cell count (neutropenia). If your child is starting treatment, this device might help you catch early signs of infection and avoid complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 0 and 17 years old.
- Your child must have been diagnosed with a solid tumor or blood cancer for the first time.
- Your child must have received their first round of chemotherapy.
- Your child's family must have some social or emotional challenges that make extra support helpful.
- Your child cannot have a severe skin condition that would prevent wearing a small monitoring device on the skin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether adding a medicine called G-CSF (which helps the body make more white blood cells) to antibiotics is better than antibiotics alone for children with cancer who develop a fever and low blood cell counts after chemotherapy.
This trial studies whether proteins in your blood can predict complications when you have a fever and very low white blood cells after cancer treatment. It aims to help doctors choose the best antibiotics early on.
This study tests a small wearable sensor that continuously tracks body temperature in children receiving cancer treatment. It may help detect fevers early, which is important because fevers can be a sign of serious infection during chemotherapy.
This trial tests a smartphone app and wearable sensor to track your temperature after leaving the hospital, alerting you or your doctors if a fever develops. It aims to catch fevers early so you can get faster care.
This study tests whether cancer patients can do their own blood counts at home using a finger-prick test. It will help see if home monitoring is a good option for people receiving chemotherapy.
This trial tests whether using a mobile app to track daily medication and weekly blood tests can help children with acute lymphoblastic leukemia (ALL) continue maintenance therapy safely at home, without needing to stay in the hospital.
Hear when a new Febrile Neutropenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.